“Efficiency integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small cell lung cancer and an activating EGFR gene mutation”. (2022) Voprosy onkologii, 67(2), pp. 246–253. doi:10.37469/0507-3758-2021-67-2-246-253.